Mar 19 |
Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2023 Earnings Call Transcript
|
Mar 19 |
LTRN: 2023 Results
|
Mar 19 |
Lantern Pharma Inc. (LTRN) Q4 2023 Earnings Call Transcript
|
Mar 18 |
Lantern Pharma Inc Reports Progress and Financials for FY 2023
|
Mar 18 |
Lantern Pharma GAAP EPS of -$0.39 beats by $0.01
|
Mar 18 |
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights
|
Mar 18 |
Earnings Scheduled For March 18, 2024
|
Mar 15 |
Lantern Pharma Announces Initial Patients Dosed in First-In-Human Clinical Trial for AI-Guided Drug-Candidate, LP-284
|
Mar 11 |
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
|
Mar 7 |
11 Best Artificial Intelligence Stocks Under $20 According To Hedge Funds
|